Asia
Shenzhen Kangtai Biological Products to Acquire 51% of Bio-Based Materials Company
Shenzhen Kangtai Biological Products (SHE:300601) plans to acquire a 51% of the subscribed but not yet paid-in equity of Beijing Kunyuan Biotechnology.The stake is equivalent to subscribed registered capital of 51 million yuan and paid-in capital of zero, according to a late night filing on Monday.Beijing Kunyuan Biotechnology researches and develops bio-based materials.
SHE:300601
